CardioSecur participates in clinical research with the overarching goal of reducing the burden of cardiovascular disease and improving disease management via innovative mobile ECG technology.
It is through our CardioSecur clinical trials program that we prove how CardioSecur:
- Leads to earlier diagnosis of cardiac events
- Allows for more precise localisation of cardiac events
- Improves the efficiency of the diagnosis, management, and treatment of cardiovascular disease
- Leads to health-economic benefits